Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-06-203614
Filing Date
2006-10-05
Accepted
2006-10-05 17:20:25
Documents
5
Period of Report
2006-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 47374
2 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT dex49.htm EX-4.9 228453
3 PROMISSORY NOTE dex1036.htm EX-10.36 18123
4 SECTION 302 CEO CERTIFICATION dex313.htm EX-31.3 2953
5 SECTION 302 CFO CERTIFICATION dex314.htm EX-31.4 2947
  Complete submission text file 0001193125-06-203614.txt   301256
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-K/A | Act: 34 | File No.: 000-21794 | Film No.: 061131917
SIC: 2836 Biological Products, (No Diagnostic Substances)